Archive | Of Interest

WA biotech discovery to improve skin cancer diagnosis

Source: The West Australian, January 2019 A Perth medical science student is commercialising a new biotechnology that is set to dramatically improve the diagnosis of melanoma skin cancer. Edith Cowan University PhD candidate Pauline Zaenker has developed a blood test that can detect melanoma by checking for a combination of biomarkers produced by a person’s […]

Read the full story

Posted in Melanoma News, Health Professionals, Of Interest

Solect Energy receives award for its efforts to educate solar workers about melanoma and sun safety

Source: Solar Power World, January 2019 Solect Energy CEO Ken Driscoll, has been honored by IMPACT Melanoma with its Keeper of the Hope Award.  The award was presented at IMPACT Melanoma’s 2018 Shades of Hope Gala which took place on Nov. 16 at the Four Seasons Hotel in Boston. Driscoll was lauded for his many contributions […]

Read the full story

Posted in Melanoma News, Health Professionals, Patients, Latest News, Of Interest

Do Targeted Agents Aid Melanoma Immunotherapy?

Source: Modern Medicine Network, January 2019 Guy Ben-Betzalel, MD, is an oncologist at the Ella Lemelbaum Institute for Immuno-Oncology in Ramat-Gan, Israel, where he treats patients with skin cancer and studies the roles of immune response in targeted antimelanoma treatment outcomes. Cancer Network spoke with Ben-Betzalel about the promise of BRAF+MEK inhibition’s interactions with antitumor immunity and […]

Read the full story

Posted in Melanoma News, Health Professionals, Of Interest

Cutting the legs off cancer

Source: Eurek Alert, January 2019 Melanoma skin cancer tumors grow larger and are more likely to metastasize due to interactions between a pair of molecules, according to experiments in mice and human cells. The results may restore the potential for a type of cancer therapy previously abandoned in clinical trials. The results also implicate one […]

Read the full story

Posted in Melanoma News, Health Professionals, Of Interest